Sexual dysfunction: overview of prevalence, etiological factors, and treatments.Sexual dysfunction sexual dysfunction
Inability to experience arousal or achieve sexual satisfaction under ordinary circumstances, as a result of psychological or physiological problems. can impact a person's ability to form or sustain intimate relationships and has been found to interact with mental health conditions such as anxiety and depression. Yet epidemiological, etiological etiological
pertaining to etiology.
the name of a disease which includes the identification of the causative agent, e.g. Streptococcus agalactiae mastitis. , and health associations to sexual dysfunctions have only begun to be explored. The result of the research to date indicates that neurovascular mechanisms may be important for both sexes, and new classes of drugs are being explored with significant treatment potential (Bancroft, 1998; Everaerd & Laan, 2000; Heaton, 1998; Rowland & Burnett, 2000).
Recent research indicates that sexual problems are highly prevalent in both sexes. Community samples estimates range from 10% to 52% of men and 25% to 63% of women (Feldman, Goldstein, Hatzichristou, Krane, & McKinlay, 1994; Frank, Anderson, & Rubenstein, 1978; Rosen, Taylor, Leiblum, & Bachman, 1993; Spector & Carey, 1990). The National Health and Social Life Survey (NHSLS NHSLS National Health and Social Life Survey ), a 1992 national probability sample of 1410 men and 1749 women between the ages of 18 and 59 years living in U.S. households, comprises our best estimate of sexual problems in the U.S. (Laumann, Gagnon, Michael, & Michaels, 1994; Laumann, Paik, & Rosen, 1999). In the analyses that included only those individuals who reported any sexual activity with a partner in the prior 12-month period, the prevalence of sexual dysfunction was 43% for women and 31% for men (Laumann, et al., 1999). Although this study did not use the Diagnostic and Statistical Manual (DSM-IV DSM-IV
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). This reference book, published by the American Psychiatric Association, is the diagnostic standard for most mental health professionals in the United States. , American Psychiatric Association The American Psychiatric Association (APA) is the main professional organization of psychiatrists and trainee psychiatrists in the United States, and the most influential world-wide. Its some 148,000 members are mainly American but some are international. , 1994) criteria, and thus does not connote con·note
tr.v. con·not·ed, con·not·ing, con·notes
1. To suggest or imply in addition to literal meaning: "The term 'liberal arts' connotes a certain elevation above utilitarian concerns" clinical dysfunction, it provides an estimate of potential sexual dysfunction, and we will often rely on these figures as the dysfunctions are discussed. Nevertheless, we must keep in mind that these are not formal clinical diagnostic categories which in fact may overestimate the prevalence (e.g., Simons & Carey, 2001), even though the Laumann et al. (1999) figures may themselves be conservative because they exclude the 139 men and 238 women who were sexually inactive in the past year.
Though few data exist, there are some general etiological indicators that have been implicated im·pli·cate
tr.v. im·pli·cat·ed, im·pli·cat·ing, im·pli·cates
1. To involve or connect intimately or incriminatingly: evidence that implicates others in the plot.
2. in specific sexual dysfunctions. For example, the Massachusetts Male Aging Study (MMAS MMAS Massachusetts Male Aging Study
MMAS MAX-MIN Ant System
MMAS Material Management and Accounting System
MMAS Multimedia Arts and Sciences
MMAS Master of Military Arts and Science (School for Advanced Military Studies, Ft. ) reported erectile dysfunction Erectile Dysfunction Definition
Erectile dysfunction (ED), formerly known as impotence, is the inability to achieve or maintain an erection long enough to engage in sexual intercourse. in 34.8% of men aged 40 to 70 years old with age, health status (cardiovascular disease Cardiovascular disease
Disease that affects the heart and blood vessels.
Mentioned in: Lipoproteins Test
cardiovascular disease , diabetes, disease-related medications, cigarette smoking), and emotional factors (depression, anger) being highly related to the erectile disorder (Feldman et al., 1994). In the NHSLS, a variety of risk factors were identified using adjusted odds ratios (Laumann et al., 1999). Demographic factors that influence reported problems included age, education, and race/ethnicity. For women, sexual problems, except for trouble lubricating, tended to decrease with age; for men, erection problems in particular increased with age. Higher education was correlated with less dysfunction. Though race and ethnicity effects were more modest, Hispanics reported the least dysfunction, followed by the White and then the Black samples, which showed higher rates. Among the health and lifestyle variables, the NHSLS found that stress and emotional problems were related to experiencing sexual problems. Health problems were more significant for men's dysfunctions and sexual pain disorders in women than for women's sexual desire and arousal problems. Reported urinary tract infections were associated with sexual arousal and pain disorders in women and erectile dysfunction in men. Among the social status variables, all categories of female sexual dysfunction were associated with decreasing household income while only erectile dysfunction was associated in men. Liberal sexual attitudes were associated only with premature ejaculation in men. Several sexual experience variables were important. Men reporting any same-sex sexual activity were more likely to experience premature ejaculation and low sexual desire than men who reported no same sex experience, though this variable did not differentiate for women. Arousal disorder in women was highly associated with their experience of adult-child sexual contact or any experience of male sexual force. Women's desire disorder was also associated with male sexual force. For men, being sexually touched before puberty was associated with a three-fold increase in erectile dysfunction and a two-fold increase in premature ejaculation and low sexual desire compared to men without this history. Men who reported sexually forcing a woman were 3.5 times as likely to report erectile dysfunction. While the MMAS and the NHSLS data sets sample only a small percentage of potential etiological factors, they suggest that sexual dysfunctions are complexly determined and highly related to physical and psychosocial dimensions of an individual's life. This implies that preventative treatment measures would be useful, and that optimal treatments require careful histories and the ability to impact psychological and physiological sexual response.
EFFICACY AND SEXUAL DYSFUNCTION TREATMENT
In treating sexual problems with either pharmacological/medical or psychological techniques, one hopes for changes in physical (genital response, orgasms) and subjective (increased desire, ease of orgasm) responses. Psychological techniques use cognitive and/or behavioral methods to change sexual problems. Historically, this position was crystallized by Masters and Johnson Masters and Johnson, pioneering research team in the field of human sexuality, consisting of the gynecologist
William Howell Masters, 1915–2001, b. Cleveland, and the psychologist
Virginia Eshelman Johnson, 1925–, b. (1970), whose work was as revolutionary in its time for impacting psychotherapy as sildenafil citrate (Viagra: Pfizer, Inc.) has been for pharmacological treatments. Medical treatments aim to change a person's physiological response. The focus of medical treatments for the past 20 years has been primarily on male erectile disorder, and only recently on premature ejaculation in men and sexual arousal and desire in women.
Before reviewing sexual dysfunction treatments, it is important to briefly note the differences between typical randomized clinical trials which test medications and those testing psychological interventions (see Heiman & Meston, 1997). These include: (a) Psychological placebos require a consideration of many variables and, under most conditions, are ethically questionable; (b) double-blind designs are not feasible in psychosexual psychosexual /psy·cho·sex·u·al/ (-sek´shoo-al) pertaining to the mental or emotional aspects of sex.
Of or relating to the mental and emotional aspects of sexuality. therapy; (c) treatment delivery systems are more variable in psychosexual therapy than in medication provision; (d) adequate comparison groups are needed and currently there are few available for psychological treatments; and (e) endpoints are more restricted and unidimensional u·ni·di·men·sion·al
Adj. 1. unidimensional - relating to a single dimension or aspect; having no depth or scope; "a prose statement of fact is unidimensional, its value being measured wholly in terms in pharmacology clinical trials than in psychosexual studies.
In 1995, the American Psychological Association The American Psychological Association (APA) is a professional organization representing psychology in the US. Description and history
The association has around 150,000 members and an annual budget of around $70m. (APA (All Points Addressable) Refers to an array (bitmapped screen, matrix, etc.) in which all bits or cells can be individually manipulated.
APA - Application Portability Architecture ) Task F6rce on the Promotion and Dissemination of Psychological Procedures proposed two categories of empirically supported treatments (ESTs): well-established and probably efficacious (APA, 1995). Well-established treatments require group studies by different investigators by showing superiority to another treatment or placebo, or by demonstrating equivalency to an established treatment in studies with adequate statistical power; or a large series of well-designed single case studies compared to another treatment or placebo; using treatment manuals and clear specification of patient/client samples.
Probably efficacious criteria are somewhat less stringent: two studies showing treatment is more effective than a waiting-list control group, or studies otherwise meeting well-established criteria, or at least two good studies demonstrating effectiveness but flawed by client sample heterogeneity, or a small series of single case design studies otherwise meeting the well-established treatment criteria. Since the original report of the task force there has been further discussion of the criteria and meaning of empirically supported treatment (e.g., Berkovec & Castonguay, 1998; Chambless & Hollon, 1998). There is recognition that some level of efficacy must be demonstrated with controlled research with a delineated population. Efficacy research is similar in scope and intent to traditional randomized clinical trial (RCT RCT Randomized Controlled Trial
RCT Regimental Combat Team (infantry regiment with their own artillery, engineers, medical and tanks)
RCT Rollercoaster Tycoon
RCT Randomized Clinical Trial
RCT Rhondda Cynon Taff ) research.
After establishing efficacy there is reason to examine treatment effectiveness or utility, referring to whether treatment can be shown to be beneficial in actual clinical practice. Effectiveness addresses the concept of generalizability that a RCT is often unable to assess since sample selection is more criteria restricted than in clinical practice. To test efficacy, quasiexperimental and nonexperimental designs may be usefully employed.
A number of sexual dysfunctions have treatment data that meet the probably efficacious criteria for an empirically supported treatment. Few meet the well-established criteria. Reasons for this are summarized elsewhere (Heiman & Meston, 1997). The primary issues have been funding and availability of comparable treatments and ethical placebos.
EMPIRICALLY SUPPORTED TREATMENTS BY SEXUAL DYSFUNCTION CATEGORY
Sexual Desire Disorders
Although a Consensus Conference was convened in the late 1990s to propose revisions to the diagnostic system for female sexual dysfunction (Basson et al., 2000), we will here use the DSM-IV (APA, 1994) criteria since all of the research to date has had the DSM 1. DSM - Data Structure Manager.
An object-oriented language by J.E. Rumbaugh and M.E. Loomis of GE, similar to C++. It is used in implementation of CAD/CAE software. DSM is written in DSM and C and produces C as output. system available and it is the major diagnostic system used in U.S. research. The DSM-IV lists two categories of sexual desire disorders, Hypoactive Sexual Desire and Sexual Aversion. Hypoactive Sexual Desire (HSD HSD Human Services Department
HSD High Speed Data
HSD Hillsboro School District (Hillsboro, OR)
HSD Hybrid Synergy Drive (Toyota/Lexus)
HSD High School Diploma
HSD Historical Society of Delaware ) is defined as persistently or recurrently deficient (or absent) sexual fantasies and desire for sexual activity. This sexual category is of special concern to women since the Laumann et al. (1994) national probability-sampled U.S. data revealed that 33.4% of women and 15.8% of men reported a lack of sexual interest for several months or more during the past year. Sexual Aversion refers to persistent or recurrent extreme aversion to, and avoidance of, genital sexual contact with a sexual partner. There are no prevalence figures available for sexual aversion but it is thought to be a rather rare disorder.
Although many different approaches have been tried on a case-by-case basis (Leiblum & Rosen, 1988), there are almost no controlled studies documenting an efficacious approach for either disorder in men or women. Recently, a waiting-list controlled study testing a cognitive-behavioral treatment for HSD has been reported to show improvement in sexual and marital functioning in women with HSD (Trudel et al., 2001). There is also one uncontrolled prepost study of "impaired sexual desire," using a modified Masters and Johnson (1970) approach with 154 British couples presenting for treatment (Hawton & Catalan, 1986). Only two of the men reported impaired sexual interest so their data can not be discussed. However, of the 57% of the women reporting impaired desire, 56% were rated as having the problem largely or fully resolved after a mean of 14.8 treatment sessions. The treatment approaches cited would be promising treatments to compare to each other or to medications in an RCT treating HSD.
There currently are no effective pharmacological agents for HSD in men or women. There is evidence that testosterone can be an effective treatment for individuals who are hypogonadal, or who have other conditions causing low levels of bioavailable testosterone (Davis, 1998; Heaton, 1998), but careful research specifically treating low sexual desire is lacking. One study has shown some promise for women who have had a hysterectomy hysterectomy (hĭstərĕk`təmē), surgical removal of the uterus. A hysterectomy may involve removal of the uterus only or additional removal of the cervix (base of the uterus), fallopian tubes (salpingectomy), and ovaries and oophorectomy Oophorectomy Definition
Oophorectomy is the surgical removal of one or both ovaries. It is also called ovariectomy or ovarian ablation. If one ovary is removed, a woman may continue to menstruate and have children. and who used a transdermal testosterone patch compared to placebo in combination with oral conjugated conjugated
estrogens, conjugated Warning - Hazardous drug!
C.E.S. equine estrogen (Shifren et al., 2000). At the higher testosterone dose (300[micro]g), the women reported increases in fantasy, masturbation, and sexual intercourse as well as greater well-being. However, the higher dose showed testosterone levels considerably above the normal premenopausal pre·me·no·paus·al
Of or relating to the years or the stage of life immediately before the onset of menopause.
premenopausal adjective range, so longer-term effects of this dose will need to be studied further. The clinical and research data raise the obvious point that the hypoactive sexual desire category would be best subdivided into logical subcategories by age and hormonal status, as well as the DSM-IV modifiers of Lifelong/Acquired and Global/Situational (Heiman, 2001).
Sexual Arousal Disorders
Two categories of sexual arousal disorders are defined by DSM-IV: Female Sexual Arousal Disorder Female Sexual Arousal Disorder Definition
Female sexual arousal disorder (FSAD) occurs when a woman is continually unable to attain or maintain arousal and lubrication during intercourse, is unable to reach orgasm, or has no desire for sexual (FSAD FSAD Female Sexual Arousal Disorder
FSAD Field-Safe Application Debugger
FSAD Full Scale Advanced Development
FSAD Force Structuring Analysis Division ) and Male Erectile Disorder (ED). In the DSM-IV, FSAD is described in terms of the inability to attain, or to maintain until completion of the sexual activity, an "adequate lubrication-swelling response of sexual excitement." A revision of this category by an international consensus panel proposed that this category include a lack of subjective excitement (Basson et al., 2000). There are no prevalence data for FSAD, and clinically it is rarely identified as separate from either sexual desire or orgasmic disorders. Of controlled studies specifically related to FSAD, none are published and few have been reported. Since the release of sildenafil citrate for men in 1998, there has been considerable interest in finding parallel agents for women. Sildenafil citrate, a phosdiesterase inhibitor type 5, has a relaxant relaxant /re·lax·ant/ (re-lak´sant)
1. lessening or reducing tension.
2. an agent that so acts.
muscle relaxant effect on human cavernous tissues (at this point still best demonstrated in the male penis as only indirect data exist for the human female). Several different pharmaceutical agents are under investigation, including those with more peripheral action on genital vasocongestion such as sildenafil citrate and l-arginine, and those acting on the brain such as apomorhine sl, a dopaminergic dopaminergic /do·pa·min·er·gic/ (do?pah-men-er´jik) activated or transmitted by dopamine; pertaining to tissues or organs affected by dopamine.
adj. chemical (Bartlik, Kaplan, Kaminetsky, Roentsch, & Goldberg, 1999; Everaerd & Laan, 2000). No differences in female sexual arousal were found when sildenafil sildenafil /sil·den·a·fil/ (sil-den´ah-fil?) a phosphodiesterase inhibitor that relaxes the smooth muscle of the penis, facilitating blood flow to the corpus cavernosum; used as the citrate salt to treat erectile dysfunction. was compared to a placebo in a double-blind study of over 500 women with FSAD in Canada, Europe, and the U.K. (Basson et al., 2000). In sexually functional premenopausal women in The Netherlands, sildenafil produced greater vaginal vasocongestion than did placebo to sexually explicit stimuli in a laboratory study. However, there was no difference in genital or subjective response when sildenafil was compared to placebo in postmenopausal post·men·o·paus·al
Of or occurring in the time following menopause.
postmenopausal Change of life Gynecology adjective Referring to the time in ♀ when menstrual periods stop for ≥ 1 yr women with FSAD (Laan, van Lunsen, Everaerd, Heiman, & Hackbert, 2000). The only study thus far to show significant changes in sexual functioning was a study of young (ages 22-28) Italian women with arousal disorders (Caruso, Intelisano, Lupo, & Agnello, 2001). All were ovulating normally and not on hormonal medications. Arousal, orgasm, and the frequency of enjoyment and vaginal intercourse improved significantly in the women treated with 25mg or 50mg of sildenafil. At this point it is unclear whether sildenafil might be effective for a specific subgroup among women with sexual dysfunction. Given the lack of genital focus of women, it is possible that genitally targeted pharmacological agents would be best compared to and combined with psychological treatments.
Male ED is a common clinical complaint, though only 10.4% of men between 18 and 59 years of age reported it being a problem in the past year (Laumann et al, 1994). ED prevalence increases with age (Feldman et al., 1994; Laumann et al., 1999). It is defined as the persistent or recurrent inability to attain or maintain an adequate erection until the completion of the sexual activity. The primary psychological treatments that have been used to treat ED are systematic desensitization and general sex therapy that includes a combination of education, sensate sen·sate or sen·sat·ed
1. Perceived by a sense or the senses.
2. Having physical sensation. focus exercises, and sexual communication skills. Of the six (N = 146 men) comparison controlled studies, systematic desensitization was found to be better than psychoanalytic treatment and an attention placebo (Heiman & Meston, 1997). Among the wait-list and own controlled studies (N = 85), masturbation, sex education, behavioral assignments, and communication skills resulted in increased satisfaction with erectile functioning, sexual frequency, and increased marital satisfaction (Heiman & Meston, 1997).
Erectile dysfunction in men is unique among the sexual dysfunctions for the variety of medical treatments available (prostheses Prostheses
A synthetic object that resembles a missing anatomical part.
Mentioned in: Microphthalmia and Anophthalmia , injections or urethral urethral
pertaining to or emanating from urethra.
urethral agenesis, urethral atresia
failure of development of all or part of the urethra: characterized by complete urine retention. A rare cause of neonatal uremia. suppositories suppositories,
n.pl solid capsules made of materials that melt at body temperature and are used to deliver medicinal substances into the rectum. of PGE-1, vacuum devices) but a completely different option for treatment began with the emergence of sildenafil (Goldstein, Lue, Padma-Nathan, Rosen, Steers, & Wicker, 1998). Sildenafil marked the beginning of an effective and relatively safe pharmacological agent for treating ED with a variety of etiologies, including psychogenic psychogenic /psy·cho·gen·ic/ (-jen´ik) having an emotional or psychologic origin.
adj or non-illness, non-injury induced erectile disorder. In addition, this medication could be taken 1 hour prior to sexual activity as opposed to continuously. The appeal and success of sildenafil has stimulated interest in other medications for ED, including other phosphodiesterase inhibitors, and they are currently in various stages of research (Rowland & Burnett, 2000).
These disorders include Female Orgasmic Disorder, Male Orgasmic Disorder, and Premature Ejaculation. Female Orgasmic Disorder is defined in the DSM-IV as persistent or recurrent delay in, or absence of, orgasm following a normal sexual excitement phase. Difficulty with orgasm is common, reported by 24.1% (Laumann et al., 1994). There are effective psychological treatments for this disorder, though treatments are more effective for primary (never experiencing orgasm) than secondary (infrequent or situational) orgasmic problems (Andersen, 1983; Heiman, 2000). Across all comparison controlled studies (N = 577), using 6 to 14 sessions, directed masturbation (DM) was more effective than systematic desensitization; and DM plus sensate focus was more effective than sensate focus alone (Heiman & Meston, 1997). Although group, individual, and couple therapies appear to be effective, comparisons between them are too infrequent to make any conclusions. For most criteria, primary orgasmic disorder fits the well-established efficacy designation, and secondary orgasmic disorder fits the probably efficacious criteria. The difficulty with these designations is that most of the studies have significant weaknesses in how well they characterize their samples.
Male Orgasmic Disorder is uncommon, with 8.3% of men reporting problems with lack of orgasm in the past year (Laumann et al., 1994) and it being rather rarely treated in clinics. There are no controlled treatment studies for this condition, though there are case examples and the original Masters and Johnson (1970) program data.
For both female and male orgasmic disorder, a new subcategory sub·cat·e·go·ry
n. pl. sub·cat·e·go·ries
A subdivision that has common differentiating characteristics within a larger category. has emerged in the past decade, related to pharmacologically induced orgasmic disorder. This refers primarily to the selective serotonin reuptake inhibitor selective serotonin reuptake inhibitor
Selective serotonin reuptake inhibitor (SSRI)
A class of antidepressants that work by blocking the reabsorption of serotonin in the brain, raising the levels of (SSRI SSRI selective serotonin reuptake inhibitor.
Selective serotonin reuptake inhibitor; a class of drugs that inhibit the reuptake of serotonin in the central nervous system, used to treat depression and other ) class of drugs, which have the known side effect of delayed or absent orgasm in men and women. Other psychotropic medications, including other antidepressants Antidepressants
Medications prescribed to relieve major depression. Classes of antidepressants include selective serotonin reuptake inhibitors (fluoxetine/Prozac, sertraline/Zoloft), tricyclics (amitriptyline/ Elavil), MAOIs (phenelzine/Nardil), and heterocyclics , have been found to affect sexual functioning but with more variable impacts and lower rates of being prescribed (Meston & Frohlich, 2000; Rosen, Lane, & Menza, 1999). Though exact frequencies are rarely documented, orgasmic disorder side effects seem to be reported to be spoken of; to be mentioned, whether favorably or unfavorably.
See also: Report in 9% to 40% of patients taking SSRIs, with females reporting symptoms more often than men (Rosen et al., 1999). There are no prospective comparative studies comparing hypothesized augmentation (to SSRI) agents (Rosen et al., 1999), though one recent report of women on fluoxetine fluoxetine /flu·ox·e·tine/ (floo-ok´se-ten) a selective serotonin reuptake inhibitor used as the hydrochloride salt in the treatment of depression, obsessive-compulsive disorder, bulimia nervosa, and premenstrual dysphoric disorder. suggests adding dopaminergic and serotonergic se·ro·to·ner·gic or se·ro·to·ni·ner·gic
Activated by or capable of liberating serotonin, especially in transmitting nerve impulses.
containing or activated by serotonin. agents did not improve sexual side effect more than placebo (Michelson, Bancroft, Targum, Kim, & Tepner, 2000). It is unlikely that pharmacologically induced orgasmic disorder can be impacted by a psychological intervention alone.
Premature ejaculation is defined as the persistent or recurrent ejaculation ejaculation /ejac·u·la·tion/ (e-jak?u-la´shun) forcible, sudden expulsion; especially expulsion of semen from the male urethra. with minimal sexual stimulation before, on, or shortly after penetration and before the person wishes it. It is the most common sexual problem reported in men, with approximately 28.5% of U.S. men reporting it to be a problem during the past year (Laumann, et al, 1994). The primary psychological intervention that has been used for premature ejaculation is the squeeze technique (Masters and Johnson, 1970). This technique involves stimulating the penis to full erection and almost to the point of ejaculation ("moment of inevitability") and then applying a firm squeeze just below the glans glans (glanz) pl. glan´des [L.] a small, rounded mass or glandlike body.
glans clito´ridis , glans of clitoris erectile tissue on the free end of the clitoris. of the penis. Stimulation then resumes and two more trials occur before the person allows himself to ejaculate ejaculate /ejac·u·late/ (e-jak´u-lat) to expel suddenly, especially semen.
ejaculate /ejac·u·late/ (e-jak´u-lat . It is usually first practiced in masturbation and then in partner sex. Although Masters and Johnson (1970) found excellent success (97% treatment success) treating 189 men with this condition, they had no comparison group. The only controlled (own-control) study testing this procedure found that foreplay foreplay /fore·play/ (for´pla) the sexually stimulating play preceding intercourse.
The sexual stimulation that precedes intercourse. duration significantly increased, as did intercourse duration (Heiman & LoPiccolo, 1983). Some of these gains decreased at 3-month follow-up post therapy (Heiman & Meston, 1997). The pause technique, a variant of the squeeze technique, is often used by clinicians (e.g., Kaplan, 1989) but there do not appear to be efficacy evaluations of this technique.
The SSRI side effect of orgasm delay has been incorporated into the pharmacological treatment of premature ejaculation. Clomipramine clomipramine /clo·mip·ra·mine/ (klo-mip´rah-men) a tricyclic antidepressant with anxiolytic activity, also used in obsessive-compulsive disorder, panic disorder, bulimia nervosa, cataplexy associated with narcolepsy, and chronic, severe , sertraline sertraline /ser·tra·line/ (ser´trah-len) a selective serotonin reuptake inhibitor used as the hydrochloride salt in the treatment of depression, obsessive-compulsive disorder, and panic disorder. , fluoxetine, and paroxetine paroxetine /par·ox·e·tine/ (pah-rok´se-ten) a selective serotonin uptake inhibitor used as the hydrochloride salt to treat depression and obsessive-compulsive, panic, and social anxiety disorders. have been tested in placebo-controlled or comparison treatment studies, and have been found to significantly increase latency to ejaculation (Althof, 1995: Althof et al., 1995; Rowland & Burnett, 2000) and sexual satisfaction (Althof, 1995). Thus pharmacological intervention can be a reliable source of improving ejaculation latency and possibly of sexual satisfaction for those men who wish to take medication for this condition (Rowland & Burnett, 2000). There is no evidence to date that the medications can be discontinued without the PE returning.
Genital Pain Disorders
The two categories of pain disorders are Dyspareunia dyspareunia /dys·pa·reu·nia/ (-pah-roo´ne-ah) difficult or painful sexual intercourse.
Difficult or painful sexual intercourse. and Vaginismus vaginismus /vag·i·nis·mus/ (vaj?i-niz´mus) painful spasm of the vagina due to involuntary muscular contraction, usually severe enough to prevent intercourse; the cause may be organic or psychogenic. . Vaginismus without concurrent dyspareunia appears to be a relatively rare condition. Over their 5-year study, Masters and Johnson (1970) treated only 29 women with vaginismus compared to 342 women who were treated for orgasmic disorders. The low prevalence of this condition may play a role in the fact that there are no treatment comparison studies. There are two uncontrolled studies (total N = 54) plus a number of case studies. Almost all studies used a gradual dilation dilation /di·la·tion/ (di-la´shun)
1. the act of dilating or stretching.
1. procedure with considerable success. Completed sexual intercourse was possible in approximately 75% to 100% of women by the end of treatment. In the past 10 years, perineal perineal /peri·ne·al/ (-ne´al) pertaining to the perineum.
The diamond-shaped region of the body between the pubic arch and the anus. biofeedback biofeedback, method for learning to increase one's ability to control biological responses, such as blood pressure, muscle tension, and heart rate. Sophisticated instruments are often used to measure physiological responses and make them apparent to the patient, who procedures have been used for both diagnosis and treatment of vaginismus, though no empirical data are available for this diagnosis (Glazer, Rodke, Swencionis, Hertz, & Young, 1995). There is considerable evidence that this is a promising and useful procedure either by itself or with dilators, and sex therapy, but to date no comparison studies have been published.
Dyspareunia generally refers to pain associated with intercourse, but the location, duration, and patterns of pain can be quite variable. Dyspareunia is defined as pain during sexual intercourse. The NSHLS survey asked about "pain during sexual activity" and found that 3% of men and 14.4% of women reported this as a problem during the past 12 months (Laumann et al., 1994). Vulvar vulvar
pertaining to or emanating from the vulva.
failure of the orifice to open may occur with imperforate anus as a congenital defect. vestibulitis syndrome (VVS VVS Verkehrs- und Tarifverbund Stuttgart (Public Transit Authority in Stuttgart, Germany)
VVS Very Very Small Inclusions (high quality of diamond)
VVS Vulvar Vestibulitis Syndrome ) is thought to be the most common subcategory of dyspareunia and it has a more precise diagnosis (Bergeron, Binik, Khalife, & Pagidas, 1997; Geotsch, 1991). There are very limited reports of treatment success with the general category of dyspareunia and no controlled studies. However, there are some suggestions from research with VVS patients that a psychologic treatment may be helpful (Bergeron, 1999; Bergeron et al., 1997; Glazer et al., 1995). Bergeron reported on a randomized ran·dom·ize
tr.v. ran·dom·ized, ran·dom·iz·ing, ran·dom·iz·es
To make random in arrangement, especially in order to control the variables in an experiment. comparison study and found that vestibulectomy resulted in significantly higher rates of improvement than biofeedback or a pain management]sex therapy intervention. However, mean levels of self-reported pain during interecourse were signifcantly lower at posttreatment for all three treatment conditions, and vestibulectomy patients were not significantly different from biofeedback patients on this measure. Perineal biofeedback may be particularly effective when there is presumed hypertonicity hypertonicity /hy·per·to·nic·i·ty/ (-to-nis´i-te) the state or quality of being hypertonic.
the state or quality of being hypertonic. of the pelvic floor muscles. Preliminary work by Glazer et al. (1995) found that after 28 weeks of biofeedback training practice, 17 out of 33 women with VVS reported pain-free intercourse.
In spite of indications of effective treatment for a notable number of women with genital pain disorders, the lack of controlled studies prevents us from concluding that there are any clearly efficacious treatments for women. Given the more recent research, we can expect that new treatments will evolve that will be combination therapies of more than one intervention for the majority of cases (Bergeron, 1999).
CONCLUSIONS AND RECOMMENDATIONS
(1.) Sexual dysfunctions are very prevalent in the United States, with individual disorder estimates ranging from 8% to 33%.
(2.) Sexual dysfunctions are correlated with other health conditions, particularly those dealing with the cardiovascular system, common diseases (diabetes, high blood pressure, heart disease), health habits (cigarette smoking and possibly high alcohol consumption), and mental health (anxiety, depression).
(3.) Adequate sexual functioning appears to be associated with personal well-being and ongoing relationship stability, though this may be more true for men than women.
(4.) Research is lacking in understanding sexual functioning, sexual disorders, and the impact of treatments on specific symptoms and broader health issues for individuals and couples.
(5.) Particular areas of treatment research that are important are (a) prevention of sexual disorders using a current knowledge from different disciplines and (b) treatments that compare and combine psychological and pharmacological approaches to dysfunctions. As has been shown in the research on depression and anxiety (e.g., Keller et al., 2000), different treatment choices are important for patient consumers and combined treatments often are more efficient and enduring.
Althof, S. E. (1995). Pharmacological treatment of rapid ejaculation. Psychiatric Clinics of North America, 18, 85-94.
Althof, S. E., Levine, M. D., Corty, E. W., Risen, C. B., Stern, E. B., & Kurit, B. A. (1995). A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. Journal of Clinical Psychiatry, 56, 402-407.
American Psychiatric Association. (1994). DSM-V: Diagnostic and statistical manual of mental disorders Diagnostic and Statistical Manual of Mental Disorders /Di·ag·nos·tic and Sta·tis·ti·cal Man·u·al of Men·tal Dis·or·ders/ (DSM) a categorical system of classification of mental disorders, published by the American Psychiatric Association, that delineates objective (4th ed.). Washington, DC: Author. American Psychological Association (1995). Training in and dissemination of empirically-validated psychological treatments: Report and recommendations. The Clinical Psychologist, 48, 3-24.
Andersen, B. L. (1983). Primary orgasmic dysfunction: Diagnostic considerations and review of treatment. Psychological Bulletin, 93, 105-136.
Bancroft, J. (1998). Central control and inhibitory mechanisms in male sexual response. International Journal of Impotence Research, 10(S-2), S40-43.
Bartlik, B., Kaplan, P., Kaminetsky, J., Roentsch, G., & Goldberg, J. (1999). Medications with the potential to enhance sexual responsivity in women. Psychiatric Annals, 29, 46-53.
Basson, R., Berman, J., Burnett, A., Derogatis, L., Ferguson, D., Fourcroy, J., Goldstein, I., Graziottin, A., Heiman, J., Lann, E., Leiblum, S., Padma-Nathan, H., Rosen, R., Segraves, K., Segraves, T., Shabsigh, R., Sipski, M., Wagner, G., & Whipple, B. (2000). Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and classifications. Journal of Urology, 163, 888-893.
Bergeron, S. (1999, June). A randomized comparison of vestibulectomy, biofeedback, and cognitive-behavioral therapy in the treatment of vulvar vestibulitis. Paper presented at the 25th Annual Meeting of the International Academy of Sex Research The International Academy of Sex Research (IASR) is a scientific society for researchers in sexology. IASR holds an annual meeting and publishes the journal Archives of Sexual Behavior. , Stony Brook, New York
Stony Brook is a hamlet (unincorporated community) (and census-designated place) located in the Town of Brookhaven in Suffolk County, New York. The population was 13,727 at the 2000 census. .
Bergeron, S., Binik, Y. M., Khalife, S., & Pagidas, K. (1997). Vulvar vestibulifts syndrome: A critical review. Clinical Journal of Pain, 13, 27-42.
Borkovec, T. D., & Castonguay, L. G. (1998). What is the scientific meaning of empirically supported therapies? Journal of Consulting and Clinical Psychology The Journal of Consulting and Clinical Psychology (JCCP) is a bimonthly psychology journal of the American Psychological Association. Its focus is on treatment and prevention in all areas of clinical and clinical-health psychology and especially on topics that appeal to a broad . 66, 136-142.
Caruso, S., Intelisano, G., Lupo, L., & Agnello, C. (2001). Premenopausal women affected by sexual arousal disorder treated with sildenafil: A double-blind, cross-over, placebo-controlled study. British Journal of Obstetrics and Gynecology obstetrics and gynecology
Medical and surgical specialty concerned with the management of pregnancy and childbirth and with the health of the female reproductive system. , 108, 623-638.
Chambless, D. L., & Hollon, S. D. (1998). Defining empirically supported therapies. Journal of Consulting and Clinical Psychology, 66, 7-18.
Davis, S. R. (1998). The role of androgens and the menopause in the female sexual response. International Journal of Impotence Research, 10 (S-2), S82-83.
Everaerd, W., & Laan, E. (2000). Drag treatments for women's sexual disorders. The Journal of Sex Research, 37, 195-204.
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., &.McKinlay, J. B. (1994). Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. Journal of Urology, 151, 54-61.
Frank, E., Anderson, C., & Rubenstein, D. (1978). Frequency of sexual dysfunction in "normal" couples. New England Journal of Medicine The New England Journal of Medicine (New Engl J Med or NEJM) is an English-language peer-reviewed medical journal published by the Massachusetts Medical Society. It is one of the most popular and widely-read peer-reviewed general medical journals in the world. , 299, 111-115.
Glazer, H. I., Rodke, G., Swencionis, C., Hertz, R., & Young, A. W. (1995). The treatment of vulvar vestibulitis syndrome. Journal of Reproductive Medicine, 40, 283-290.
Goetsch, M. F. (1991). Vulvar vestibulitis: Prevalence and historic features in a general gynecologic gynecologic /gy·ne·co·log·ic/ (gi?ne-) (jin?e-kah-loj´ik) pertaining to the female reproductive tract or to gynecology. practice population. American Obstetrics and Gynecology, 161, 1609-1617.
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Stern, W. D., & Wicker, P. A. (1998). Oral sildenafil in the treatment of erectile dysfunction. New England Journal of Medicine, 338, 1397-1404.
Hawton, K., & Catalan, J. (1986). Prognostic factors in sex therapy. Behaviour Research and Therapy, 24, 377-385.
Heaton, J. (1998). Neural and pharmacological determinants of erection. International Journal of Impotence Research, 10 (S-2), S34-39.
Heiman, J. R. (2000). Orgasmic disorders in women. In S. R. Leiblum & R. C. Rosen (Eds.), Principles and practice of sex therapy (3rd ed.; pp. 118-153). New York: Guilford.
Heiman, J. R. (2001). Sexual desire in human relationships. In W. Everaerd & E. Laan (Eds.), Sexual appetite, desire and motivation (pp. 117-134). Amsterdam: The Royal Netherlands Academy of Arts and Sciences The Koninklijke Nederlandse Akademie van Wetenschappen (KNAW, Royal Netherlands Academy of Arts and Sciences) is an organisation dedicated to the advancement of science and literature in the Netherlands. .
Heiman, J. R., & LoPiccolo, J. (1983). Clinical outcome of sex therapy. Archives of General Psychiatry Archives of General Psychiatry is a monthly professional medical journal published by the American Medical Association. Archives of General Psychiatry publishes original, peer-reviewed articles about psychiatry, mental health, behavioral science and related fields. , 40, 443-449.
Heiman, J. R., & Meston, M. (1997). Empirically validated treatment for sexual dysfunction. Annual Review of Sex Research, 8, 148-194.
Kaplan, H. S. (1989). Premature ejaculation: Overcoming premature ejaculation. New York: Brunner/Mazel.
Keller, M. F., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russel, J. M., Thase, M. E., Trivedi, M. H., & Zajecka, J. (2000). A comparison of nefazodone nefazodone /ne·fa·zo·done/ (ne-fa´zo-don) an antidepressant, used as the hydrochloride salt.
n. , the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. The New England Journal of Medicine, 342, 1462-1470.
Laan, E., van Lunsen, R. H. W., Everaerd, W., Heiman, J. R., & Hackbert, L. (2000, June). The effect of sildenafil on women's genital and subjective sexual response. Paper presented at the 26th Annual Meeting of the Internaftonal Academy of Sex Research, Pads, France.
Laumann, E. O., Gagnon, J. H., Michael, R. T., & Michaels, S. (1994). The social organization of sexuality: Sexual practices in the United States. Chicago: University of Chicago Press The University of Chicago Press is the largest university press in the United States. It is operated by the University of Chicago and publishes a wide variety of academic titles, including The Chicago Manual of Style, dozens of academic journals, including .
Laumann, E. O., Paik, A., & Rosen, R. C. (1999). Sexual dysfunction in the United States: Prevalence and predictors. Journal of the American Medical Association JAMA: The Journal of the American Medical Association is an international peer-reviewed general medical journal, published 48 times per year by the American Medical Association. JAMA is the most widely circulated medical journal in the world. , 281: 537-544.
Leiblum, S. R., & Rosen, R. C. (Eds.). (1988). Sexual desire disorders. New York: Guilford.
Masters, W., & Johnson, V. (1970). Human sexual inadequacy. Boston: Little, Brown.
Meston, C. M., & Frohlich, P. F. (2000). The neurobiology Neurobiology
Study of the development and function of the nervous system, with emphasis on how nerve cells generate and control behavior. The major goal of neurobiology is to explain at the molecular level how nerve cells differentiate and develop their of sexual function, Archives of General Psychiatry, 57, 1012-1030.
Michelson, D., Bancroft, J., Targum, S., Kim, Y., & Tepner, R. (2000). Female sexual dysfunction associated with antidepressant antidepressant, any of a wide range of drugs used to treat psychic depression. They are given to elevate mood, counter suicidal thoughts, and increase the effectiveness of psychotherapy. medication: A randomized, placebo-controlled study of pharmacolgic intervention. American Journal of Psychiatry The American Journal of Psychiatry (AJP) is the most widely read psychiatric journal in the world. It covers topics on biological psychiatry, treatment innovations, forensic, ethical, economic, and social issues. , 157, 239-243.
Rosen, R. C., Lane, R. M., & Menza, M. (1999). Effects of SSRIs on sexual function: A critical review. Journal of Clinical Psychopharmacology psychopharmacology (sī'kōfär'məkŏl`əjē), in its broadest sense, the study of all pharmacological agents that affect mental and emotional functions. , 19, 67-85.
Rosen, R. C., Taylor, J. F., Leiblum, S. R., & Bachman, G. A. (1993). Prevalence of sexual dysfunction in women: Results of a survey of 329 women in an outpatient gynecological gynecological /gy·ne·co·log·i·cal/ (-kah-loj´i-k'l) gynecologic. clinic. Journal of Sex and Marital Therapy, 19, 171-188.
Rowland, D. L., & Burnett, A. L. (2000). Pharmacology in the treatment of male sexual dysfunction. The Journal of Sex Research, 37, 226-245.
Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., Caramelli, K. E., & Mazer, N. A. (2000). Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. The New England Journal of Medicine, 343, 682-731.
Simons, J. S., & Carey, M. P. (2001). Prevalence of sexual dysfunctions: Results from a decade of research. Archives of Sexual Behavior Archives of Sexual Behavior is an academic sexology journal and the official publication of the International Academy of Sex Research.
Contributions consist of empirical research (both quantitative and qualitative), theoretical reviews and essays, clinical case , 30, 177-217.
Spector, I. P., & Carey, M. P. (1990). Incidence and prevalence of the sexual dysfunctions: A critical review of the empirical literature. Archives of Sexual Behavior, 19, 389-408.
Trudel, G., Marchand, A, Ravart, M., Aubin, S., Turgeon, I., & Fortier, P. (2001). The effect of a cognitive-behavioral group treatment program on hypoactive sexual desire in women. Sexual and Relationship Therapy, 16, 145-164.
Julia R. Heiman University of Washington School of Medicine
Address correspondence to Julia R. Heiman, Ph.D., University of Washington Outpatient Psychiatry Center, 4225 Roosevelt Way NE, Suite 306, Seattle, WA 98105; e-mail: email@example.com.